KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Cash & Equivalents (2016 - 2025)

Maxlinear (MXL) has disclosed Cash & Equivalents for 16 consecutive years, with $72.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 38.6% to $72.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72.8 million through Dec 2025, down 38.6% year-over-year, with the annual reading at $72.8 million for FY2025, 38.6% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $72.8 million at Maxlinear, down from $111.9 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $191.9 million in Q1 2024, with the low at $105000.0 in Q4 2021.
  • Average Cash & Equivalents over 5 years is $61.6 million, with a median of $1.1 million recorded in 2023.
  • Peak annual rise in Cash & Equivalents hit 152534.23% in 2021, while the deepest fall reached 99.93% in 2021.
  • Over 5 years, Cash & Equivalents stood at $105000.0 in 2021, then skyrocketed by 835.24% to $982000.0 in 2022, then increased by 7.03% to $1.1 million in 2023, then skyrocketed by 11182.11% to $118.6 million in 2024, then crashed by 38.6% to $72.8 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $72.8 million, $111.9 million, and $1.3 million for Q4 2025, Q3 2025, and Q1 2025 respectively.